Clinical trials
Insulin clinical trials
Below are recruiting insulin clinical trials, each written for real people, not researchers. We’re tracking 351 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07521371Enrolling by invitation
Intranasal Insulin for Autism in Children and Young Adults
This study observes how intranasal insulin (a form of insulin delivered through the nose) affects children and young adults with autism spectrum disorder who are already using or planning to use it as part of their regular care. Researchers will track changes in behavior and social skills over about 6 months.
Spring, TexasAges 4–21 - NCT07422831Enrolling by invitation
Intermittent glucose sensor use for type 2 diabetes
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
Aurora, ColoradoAges 18 years+ - NCT07351318Enrolling by invitation
Insulin sensitivity in type 1 diabetes pregnancies
This study looks at how well the body uses insulin in women who had type 1 diabetes during a recent pregnancy. If you used a Dexcom CGM and Tandem insulin pump while pregnant, your data could help researchers better understand insulin needs in pregnancy.
Chicago, IllinoisAges 18 years+ - NCT07239700Enrolling by invitation
Buzzy and TickleFlex for easier insulin shots in kids
This study tests two devices, Buzzy and TickleFlex, to see if they can reduce pain and fear during insulin injections in children with type 1 diabetes. It may help make daily injections more comfortable.
Hakkari, CentreAges 6–12 - NCT07234500Enrolling by invitation
Mobile app to help manage type 1 diabetes insulin doses
This trial tests a mobile app that helps you adjust your insulin doses. It is for people with type 1 diabetes who have high blood sugar levels and are already taking multiple daily insulin injections.
Basra, BasrahAges 15 years+ - NCT07117240Enrolling by invitationPhase 4
GLP-1 drugs for steroid-induced diabetes
This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can safely and effectively treat high blood sugar caused by long-term steroid use. It may help people with type 2 diabetes or steroid-induced diabetes who take oral steroids for conditions like asthma, arthritis, or kidney disease.
Warsaw, WarsawAges 18 years+ - NCT07094776Enrolling by invitation
MG53 protein levels in women with PCOS
This study measures a protein called MG53 in the blood of women with and without PCOS to see if it could be a marker for the condition. If you have PCOS and are not taking certain medications, you may be able to join and help researchers better understand the disease.
Gaziosmanpaşa, IstanbulAges 18–45 - NCT06826807Enrolling by invitation
Lifestyle change study for fatty liver disease
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
Bangkoknoi, BangkokAges 18–80 - NCT06765655Enrolling by invitation
Blood sugar monitoring during surgery to prevent infections
This trial checks if monitoring and treating blood sugar levels during long surgeries can lower the risk of infections and other problems afterward. It is for adults having any surgery expected to last 2 hours or more.
Albany, New YorkAges 18 years+ - NCT06724991Enrolling by invitation
Lower vs standard insulin dose for high potassium in ER
This study compares a lower dose versus a standard dose of insulin and dextrose (sugar water) to treat moderately high potassium levels in emergency department patients. It aims to see if a lower dose works just as well with fewer side effects.
Kuala LumpurAges 18–100 - NCT06334666Enrolling by invitation
Step counting for fatty liver disease management
This trial tests if using a pedometer to track daily steps can help people with a type of fatty liver disease (called MASLD) become more active and improve their health. It may be a good fit if you are not already very active and want to try a simple way to manage your condition.
Bangkoknoi, BangkokAges 18 years+ - NCT06154135Enrolling by invitation
Test of DBLG1 closed-loop insulin delivery for type 1 diabetes
This study tests how well a new closed-loop insulin delivery system (DBLG1) helps manage blood sugar and improves quality of life for adults with type 1 diabetes. If you are starting this system, the study will track your glucose control and ask about your daily experiences.
AalstAges 18 years+ - NCT05530356Enrolling by invitation
Study of kidney blood flow and insulin resistance in youth
This study looks at how well insulin is working and how the kidneys use energy by measuring kidney blood flow. It compares obese young people with and without type 2 diabetes to lean controls, using a PET scan (a special imaging test).
Aurora, ColoradoAges 12–26 - NCT04209816Enrolling by invitation
Genetics study on fatty liver and cholesterol problems
This is a research study testing whether specific gene changes are linked to fatty liver and a cholesterol pattern that raises heart risk. It may help researchers understand who is most likely to develop these conditions and why, which could guide future prevention.
HelsinkiAges 18–70 - NCT03308773Enrolling by invitation
Prevention program for people at risk of type 2 diabetes
This trial looks at a personalized prevention approach for people who are at risk of developing type 2 diabetes. It may help by targeting your specific health factors before diabetes starts.
Ages 18–100
Hear when a new Insulin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for insulin?
- Yes. Clin2 currently lists 351 recruiting insulin studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a insulin trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a insulin trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.